Abstract Synovial sarcoma and rhabdomyosarcoma are two high-grade soft tissue sarcoma subtypes that occur in adolescents and young adults. Managing these malignancies in patients in this age bracket poses various clinical problems, partly because different therapeutic approaches are sometimes adopted by pediatric and adult oncologists, even though they are dealing with the same condition. In this review, the doubts concerning how best to manage soft tissue sarcomas in patients between pediatric and adult ages lead up to a more general discussion of the issue of access to optimal cancer services for adolescents and young adults a subset of patients acknowledged as being under-represented in clinical trials on therapies that may improve thei...
The current article focuses on non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), the heterogeneous g...
Rhabdomyosarcoma (RMS) is a typical tumour of childhood but can occur at any age. Several studies ha...
Adolescents with cancer are enrolled in clinical trials at far lower rates than children. This repor...
Item does not contain fulltextSurvival outcomes for adolescent and young adult patients with soft ti...
Survival outcomes for adolescent and young adult patients with soft tissue sarcomas lag behind those...
Rhabdomyosarcoma (RMS) is a rare type of soft tissue sarcoma that mainly affects children, but also ...
Rhabdomyosarcoma (RMS) is a rare type of soft tissue sarcoma that mainly affects children, but also ...
Rhabdomyosarcoma (RMS) is a rare type of soft tissue sarcoma that mainly affects children, but also ...
Abstract BACKGROUND: In many types of cancer, the survival rates are reported to be less favorable ...
Diana A Steppan, Christine A Pratilas, David M Loeb Division of Pediatric Oncology, The Sidney Kimme...
BACKGROUND: Treatment of initially unresectable nonrhabdo soft tissue sarcomas (NRSTS) in pediatric...
BACKGROUND: Treatment of initially unresectable nonrhabdo soft tissue sarcomas (NRSTS) in pediatric...
BACKGROUND. Treatment of initially unresectable nonrhabdo soft tissue sarcomas (NRSTS) in pediatric ...
Background: In recent years, there has been growing awareness of the distinct characteristics of ado...
BACKGROUND: Adolescent and young adult patients with rhabdomyosarcoma often have poorer outcomes tha...
The current article focuses on non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), the heterogeneous g...
Rhabdomyosarcoma (RMS) is a typical tumour of childhood but can occur at any age. Several studies ha...
Adolescents with cancer are enrolled in clinical trials at far lower rates than children. This repor...
Item does not contain fulltextSurvival outcomes for adolescent and young adult patients with soft ti...
Survival outcomes for adolescent and young adult patients with soft tissue sarcomas lag behind those...
Rhabdomyosarcoma (RMS) is a rare type of soft tissue sarcoma that mainly affects children, but also ...
Rhabdomyosarcoma (RMS) is a rare type of soft tissue sarcoma that mainly affects children, but also ...
Rhabdomyosarcoma (RMS) is a rare type of soft tissue sarcoma that mainly affects children, but also ...
Abstract BACKGROUND: In many types of cancer, the survival rates are reported to be less favorable ...
Diana A Steppan, Christine A Pratilas, David M Loeb Division of Pediatric Oncology, The Sidney Kimme...
BACKGROUND: Treatment of initially unresectable nonrhabdo soft tissue sarcomas (NRSTS) in pediatric...
BACKGROUND: Treatment of initially unresectable nonrhabdo soft tissue sarcomas (NRSTS) in pediatric...
BACKGROUND. Treatment of initially unresectable nonrhabdo soft tissue sarcomas (NRSTS) in pediatric ...
Background: In recent years, there has been growing awareness of the distinct characteristics of ado...
BACKGROUND: Adolescent and young adult patients with rhabdomyosarcoma often have poorer outcomes tha...
The current article focuses on non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), the heterogeneous g...
Rhabdomyosarcoma (RMS) is a typical tumour of childhood but can occur at any age. Several studies ha...
Adolescents with cancer are enrolled in clinical trials at far lower rates than children. This repor...